Advertisement

Topics

MyoKardia’s Phase II trial for oHCM drug meets endpoints

19:00 EDT 7 Aug 2017 | Net Resources International

MyoKardia has reported positive top-line results from the first cohort of its Phase II PIONEER-HCM clinical trial of mavacamten in patients with symptomatic, obstructive hypertrophic cardiomyopathy (oHCM).

Original Article: MyoKardia’s Phase II trial for oHCM drug meets endpoints

NEXT ARTICLE

More From BioPortfolio on "MyoKardia’s Phase II trial for oHCM drug meets endpoints"

Quick Search
Advertisement
 

Relevant Topics

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...